An interventional study of Vein-Viewer Vision in Cardiovascular Diseases, sponsored by Fondation Ophtalmologique Adolphe de Rothschild. Completed at 2 sites in France. Open to participants aged Up to 7 Years. Per ClinicalTrials.gov, last updated 2014-08-06.
Sponsored by Fondation Ophtalmologique Adolphe de Rothschild · Not applicable and Interventional
Our hypothesis is that a new medical device called Vein-Viewer Vision helps to see peripheral veins in children having forecasted difficult venous access and could facilitate the venous access.The main goal is to reduce the time necessary to get a venous access during the inhalation anesthesia induction.
Randomized study comparing the delay of peripheral access with or without using the device. Monosite study, including children undergoing surgery.
4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.
This study's enrollment of 311 is above the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →Fondation Ophtalmologique Adolphe de Rothschild is the lead sponsor of 311 studies on the registry; 77 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
A medical device called Vein-Viewer Vision
Device: Vein-Viewer Vision
in the second arm, we use no medical device
A medical device called Vein-Viewer Vision
reduce the time necessary to find the venous access during inhalation anesthesia induction
Time frame: 1 day of anesthesia
This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondation Ophtalmologique Adolphe de Rothschild